BATF2 antibody

Synonyms:B ATF 2 antibody, BATF2 antibody, basic leucine zipper transcription factor antibody, ATF-like 2 antibody
Catalogue No.:FNab00808Reactivity:Human
Host:RabbitTested Application:ELISAA, WB, IP
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
BATF2 antibody
Catalogue No.
FNab00808
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
basic leucine zipper transcription factor, ATF-like 2
Alternative Names
B ATF 2 antibody, BATF2 antibody, basic leucine zipper transcription factor antibody, ATF-like 2 antibody
UniProt ID
Q8N1L9
Observed MW
29 kDa
Application
Tested Applications
ELISAA, WB, IP
Recommended dilution
WB: 1:200-1:1000; IP: 1:200-1:1000
Validated Images
IP Result of anti-BATF2 (IP:FNab00808, 3ug; Detection:FNab00808 1:300) with HeLa cells lysate 1200ug.
Background
AP-1 family transcription factor that controls the differentiation of lineage-specific cells in the immune system. Following infection, participates in the differentiation of CD8(+) thymic conventional dendritic cells in the immune system. Acts via the formation of a heterodimer with JUN family proteins that recognizes and binds DNA sequence 5'-TGA[CG]TCA-3' and regulates expression of target genes(By similarity). Selectively suppresses CYR61/CCN1 transcription and hence blocks the downstream cell proliferation signals produced by CYR61 and inhibits CYR61-induced anchorage-independent growth and invasion in several cancer types, such as breast cancer, malignant glioma and metastatic melanoma. Possibly acts by interfering with AP-1 binding to CYR61 promoter.